喉和下咽癌的喉保存策略的国际共识

Marco Ferrari, Francesca Mularoni, Davide Smussi, Piergiorgio Gaudioso, Pierluigi Bonomo, Jeppe Friborg, Maria Grazia Ghi, Vincent Gregoire, Kevin Harrington, Keith Hunter, Roberto Maroldi, Rosemary Martino, Ricard Mesia, Giorgio Peretti, Amanda Psyrri, Antonio Schindler, Giovanni Succo, Petr Szturz, Isabel Vilaseca, Piero Nicolai, David Viros Porcuna
{"title":"喉和下咽癌的喉保存策略的国际共识","authors":"Marco Ferrari, Francesca Mularoni, Davide Smussi, Piergiorgio Gaudioso, Pierluigi Bonomo, Jeppe Friborg, Maria Grazia Ghi, Vincent Gregoire, Kevin Harrington, Keith Hunter, Roberto Maroldi, Rosemary Martino, Ricard Mesia, Giorgio Peretti, Amanda Psyrri, Antonio Schindler, Giovanni Succo, Petr Szturz, Isabel Vilaseca, Piero Nicolai, David Viros Porcuna","doi":"10.1016/s1470-2045(25)00020-8","DOIUrl":null,"url":null,"abstract":"This Policy Review summarises an expert Delphi consensus process on larynx-preservation treatments in patients affected by intermediate-to-advanced laryngeal or hypopharyngeal squamous cell carcinoma. The experts, who represented all perspectives involved in multidisciplinary management of these patients and included patient representatives, approved 137 consensus statements that cover several relevant areas in the field of larynx-preserving treatments. Statements are grouped in the following topics: granular indications for T2–T3 cancer, indications for T4a cancer, indications for salvage organ-preservation surgery after chemoradiation failure, laryngeal function at baseline, which comorbidities are contraindications and to what extent, organ preservation in older patients: selection criteria, post-treatment surveillance, prognostic and predictive factors, listening to the patient's preferences: tools and implementation, prehabilitation and rehabilitation protocols, and cost-effectiveness of different laryngeal preservation approaches. We present a high-level summary of the results of the consensus process, with detailed reference to the full list of statements and supporting literature.","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer\",\"authors\":\"Marco Ferrari, Francesca Mularoni, Davide Smussi, Piergiorgio Gaudioso, Pierluigi Bonomo, Jeppe Friborg, Maria Grazia Ghi, Vincent Gregoire, Kevin Harrington, Keith Hunter, Roberto Maroldi, Rosemary Martino, Ricard Mesia, Giorgio Peretti, Amanda Psyrri, Antonio Schindler, Giovanni Succo, Petr Szturz, Isabel Vilaseca, Piero Nicolai, David Viros Porcuna\",\"doi\":\"10.1016/s1470-2045(25)00020-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This Policy Review summarises an expert Delphi consensus process on larynx-preservation treatments in patients affected by intermediate-to-advanced laryngeal or hypopharyngeal squamous cell carcinoma. The experts, who represented all perspectives involved in multidisciplinary management of these patients and included patient representatives, approved 137 consensus statements that cover several relevant areas in the field of larynx-preserving treatments. Statements are grouped in the following topics: granular indications for T2–T3 cancer, indications for T4a cancer, indications for salvage organ-preservation surgery after chemoradiation failure, laryngeal function at baseline, which comorbidities are contraindications and to what extent, organ preservation in older patients: selection criteria, post-treatment surveillance, prognostic and predictive factors, listening to the patient's preferences: tools and implementation, prehabilitation and rehabilitation protocols, and cost-effectiveness of different laryngeal preservation approaches. We present a high-level summary of the results of the consensus process, with detailed reference to the full list of statements and supporting literature.\",\"PeriodicalId\":22865,\"journal\":{\"name\":\"The Lancet Oncology\",\"volume\":\"47 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s1470-2045(25)00020-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s1470-2045(25)00020-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本政策综述总结了中晚期喉部或下咽鳞状细胞癌患者喉保存治疗的专家德尔菲共识过程。这些专家代表了涉及这些患者的多学科管理的所有观点,包括患者代表,批准了137份共识声明,涵盖了喉保留治疗领域的几个相关领域。陈述按以下主题分组:T2-T3癌的颗粒指征,T4a癌的指征,放化疗失败后补助性器官保存手术的指征,基线时的喉功能,哪些合并症是禁忌症以及禁忌症的程度,老年患者的器官保存:选择标准,治疗后监测,预后和预测因素,倾听患者的偏好。工具和实施,预适应和康复方案,以及不同喉保存方法的成本效益。我们对协商一致进程的结果提出一份高级别摘要,详细参考声明和支持文献的完整清单。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer
This Policy Review summarises an expert Delphi consensus process on larynx-preservation treatments in patients affected by intermediate-to-advanced laryngeal or hypopharyngeal squamous cell carcinoma. The experts, who represented all perspectives involved in multidisciplinary management of these patients and included patient representatives, approved 137 consensus statements that cover several relevant areas in the field of larynx-preserving treatments. Statements are grouped in the following topics: granular indications for T2–T3 cancer, indications for T4a cancer, indications for salvage organ-preservation surgery after chemoradiation failure, laryngeal function at baseline, which comorbidities are contraindications and to what extent, organ preservation in older patients: selection criteria, post-treatment surveillance, prognostic and predictive factors, listening to the patient's preferences: tools and implementation, prehabilitation and rehabilitation protocols, and cost-effectiveness of different laryngeal preservation approaches. We present a high-level summary of the results of the consensus process, with detailed reference to the full list of statements and supporting literature.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信